The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

According to The Business Research Company’s 2023 report, the global wildlife health market is projected to increase from $2.02 billion in 2022 to $2.26 billion in 2023, with an 11.7% CAGR, and is anticipated to reach $3.35 billion in 2027 at a 10.4% CAGR

What was the major driver in the wildlife health market?
The rising zoonotic disease incidence propels the wildlife health market. Zoonotic diseases can transmit between animals and humans, fostering the development of health products for wildlife. In Europe, zoonotic disease cases increased from 120,946 in 2020 to 127,840 in 2021. Salmonellosis, the second most reported zoonotic disease, affected 60,050 individuals in 2022, compared to 52,702 in 2020. Consequently, heightened zoonotic disease prevalence drives wildlife health market growth.

View More On The Wildlife Health Market Report 2023 – https://www.thebusinessresearchcompany.com/report/wildlife-health-global-market-report

What was the key trend in the wildlife health market?
Technological advancements are a prominent trend in the wildlife health market, with major companies incorporating new technologies for market competitiveness. In August 2021, Merck Animal Health, a US-based animal health vaccine and pharmaceutical manufacturer, introduced the WHISPER ON ARRIVAL technology, featuring specialized sound collection and predictive algorithms for assessing Bovine Respiratory Disease (BRD) risk, aiding farmers and veterinarians in decision-making.

Which was the largest region in the wildlife health market?
North America was the largest region in the wildlife health market in 2022. The regions covered in wildlife health report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the wildlife health market prominent players?
Major players in the wildlife health market are Bayer AG, Novartis AG, Merck & Co Inc., Boehringer Ingelheim International GmbH, CSL Limited, Zoetis Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Génia USA Inc., Ceva Santé Animale, Orion Corporation, Virbac Group, Royal Canin, Emergent BioSolutions Inc., Ceva Santé Animale Group, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Dechra Pharmaceuticals, Huvepharma, Vétoquinol, Vetoquinol S.A., Indian Immunologicals Limited, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Animalcare Group plc, Pneu-Dart Inc., and PetAg, Inc.

Key wildlife health market segments
The global wildlife health market is segmented –
1) By Animal Type: Mammals, Birds, Fish, Reptiles, Amphibians
2) By Product: Medicine, Equipment And Consumables
3) By Route of Administration: Oral, Injectable, Other Routes Of Administration
4) By End-User: Zoos, Wildlife Sanctuaries, Wildlife Rescue And Rehab Centers, Other End Users

Request A Sample Of The Global Wildlife Health Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12183&type=smp

The Wildlife Health Global Market Report 2023  provides a comprehensive overview on the wildlife health market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Healthcare Services Global Market Report 2023
Healthcare Workforce Management System Global Market Report 2023
Healthcare Analytical Testing Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model